MedPath

Tamzor

Brand Name: Tamzor

Generic Name: Tamsulosin Hydrochloride

Active
Registration Number

DRP-8237-02

Dosage Form

Prolonged-Release Capsule

Issuance Date

February 2, 2024

Expiry Date

June 18, 2029

Product Information

Philippine FDA product specifications and classification details

Product Specifications

Dosage Strength400 mcg
PackagingAlu/Alu Blister Pack x 7's (Box of 28's)

Classification

C
Classification
Prescription Drug (Rx)
P
Pharmacologic
Alpha-adrenoreceptor antagonists
A
Application
Renewal
Philippine FDA Classification

Active Ingredients (1)

Complete list of active ingredients in this pharmaceutical product.

Tamsulosin HydrochlorideActive
Monograph: Tamsulosin

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

Product

Company

Legal

© 2025 MedPath, Inc. All rights reserved.

MedPath - Medical Intelligence Platform